• In this issue we discuss the importance of vaccination for children under 5 to prevent debilitating and potentially fatal diseases. We also visit South Africa, where one young woman's story illustrates the critical need for access to medicines, and two MSF field workers in war-torn Syria recount their experiences.

  • A forgotten war in northern Uganda. Violence in Ivory Coast. MSF's efforts to fight measles in Darfur. Mental health care in times of conflict. Responding to emergencies in the Congo. On the frontlines of AIDS treatment. Closing programs in Iraq. All in this issue of Alert.

  • The project coordinator of an MSF team in Abidjan, Ivory Coast, kept a diary describing the tense and often overwhelming period of fighting when staff worked continuously to treat the wounded and sick. And, an MSF study in Niger shows how effective ready-to-use foods can be in a malnutrition emergency.

  • In this issue, we take you inside the neglected crisis in Central African Republic, in addition to stories on Chad, access to medicines, and surgery in war-torn Syria.

  • In this issue, we focus on MSF's work in the Democratic Republic of Congo, where the ongoing conflict has physically and emotionally traumatized its people. We also consider other pertinent health and medical issues, such as Trans-Pacific Partnership; drug-resistent tuberculosis; and Rohingya refugees in Bangladesh.

  • In this issue, MSF staff answer fundamental questions about our operations—from how we recruit staff, respond to emergencies, and deliver supplies, to how we close projects and share our medical findings with the global health community.

  • Welcome to our new Alert. This is the first issue of MSF-USA’s re-designed quarterly newsletter, and we hope you like it. This issue of Alert highlights devastating crises in South Sudan and Syria, conflict-related emergencies that are causing mass casualties and extensive displacement. In both places (and in neighboring countries), our medical teams are doing as much as they can to ease suffering and save lives.

  • Two years after a 7.0-magnitude earthquake left much of the country's already fragile infrastructure in tatters, the people of Haiti remain in desperate need of assistance. In this issue, a look at Drouillard Hospital, an MSF-run facility in the Cite Soleil slum of Port-au-Prince where MSF provides the city's only free treatment for severe burns. Also in this issue: a project update on MSF's efforts to combat chronic malnutrition in Africa's Sahel region, an interview with the head of MSF's Emergency Team and a field journal from HIV/AIDS Policy Adviser Sharonann Lynch, who recently visited an innovative HIV care program in rural Mozambique.

  • While MSF has been unable to work directly in Syria, it has collected testimonies from wounded patients treated outside the country and from doctors inside Syria. These testimonies point to a coordinated crackdown on the provision of urgent medical care for people wounded in Syria's ongoing violence. Also in this issue: MSF field journals from Gogrial and Doro in South Sudan, an interview with Emmanuel Baron, executive director of Epicentre, and photos from MSF's trauma center in Kunduz, Afghanistan.

  • This special "Year in Pictures" issue brings you images from MSF's activities all over the world in 2011. These photos chronicle the response to the humanitarian crisis in the Horn of Africa; ongoing programs in conflict-affected areas of Afghanistan, Ivory Coast, Libya, and others; the birth of South Sudan, the world's newest nation; MSF's continuing work in the Democratic Republic of Congo; and more. Also read a new Field Journal from an MSF nurse who spent 14 months in Haiti providing care in the aftermath of the earthquake.


MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.


September 29, 2015

On September 28, Doctors Without Borders/Médecins Sans Frontières' (MSF) took advantage of Indian Prime Minister Narendra Modi being in New York City to send him a message. Thanks to the country's patent laws, India is the pharmacy to the developing world; MSF sources 80% of its HIV drugs from India among other essential medicines. The U.S. is pressuring PM Modi to make India's patent laws more restrictive, which would benefit big pharma companies and cause millions of people to lose access to affordable medicines. MSF is urging PM Modi not to give in to U.S. pressure.

September 28, 2015

NEW YORK—As US president Barack Obama and Indian prime minister Narendra Modi meet in New York today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that US pressure on India to change its intellectual property policies could result in millions of people around the world losing their lifeline of affordable medicines.

July 21, 2015

MSF wants Indian Prime Minister Modi to reject any external proposal that undermines the production of affordable generic medicines in India, the "pharmacy of developing world."

June 12, 2015

New Delhi/GenevaThe international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today launched a global campaign urging Indian Prime Minister Narendra Modi to stand strong in the face of intensifying multinational pressure to change India’s laws and policies that would severely restrict production of affordable medicines, upon which millions of people around the world depend.

April 07, 2015

MSF published evidence from its community-based management of acute malnutrition program in Bihar, India, which revealed that it has successfully achieved a cure rate of 88.4 percent among severely acute malnourished children who completed treatment.

January 26, 2015

Secret meeting this week in New York a chance to remove provisions that threaten access to lifesaving medicines.

January 23, 2015

New intellectual property "think tank" draft policy already showing alarming trend.

January 14, 2015

The Indian Patent Controller today rejected one of Gilead’s key patent applications, which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or $1,000 per pill in the US, has caused a worldwide debate on the pricing of patented medicines. A study from Liverpool University showed that sofosbuvir could be produced for as little as $101 for a three-month treatment course.

October 31, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2014 United States Trade Representative (USTR) Special 301 Out-of-Cycle Review of India’s intellectual property legal regime and policies.

September 26, 2014

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.